Abstracts

Cost Savings Modeling of Telehealth Services for Hepatitis C Virus Infection, Cherokee Nation

Background: American Indian and Alaska Native (AI/AN) people are disproportionately affected by hepatitis c virus (HCV) infection with the highest rate of acute HCV infection (2.7 per 100,000) and HCV-related mortality (10.17 per 100,000) compared with other races in the US. Telehealth programs using the Extension for Community Healthcare Outcomes (ECHO) Model® are effective in…

Using County Notification Data to Characterize Recently Reported Hepatitis C Cases, Los Angeles

Background: Hepatitis C remains a public health problem with continued incidence and a high proportion of individuals either unaware of their infection or untreated. Using the Los Angeles County hepatitis C registry of notified cases, the University of Southern California and the Los Angeles County Department of Public Health established a novel HCV case-management program.…

Community Pop-Up Clinic: Cascade of Care and HCV Treatment of Vancouver’s Inner-City PWID Population

Background: Several strategies have been proposed to identify HCV-infected inner-city residents, engage them in care, provide them with antiviral therapy, establish conditions to maximize treatment completion and cure achievement. Elimination of HCV infection as a public health concern by the end of this decade will require a concerted effort in all target populations, including vulnerable…

Env Conformational Flexibility Modulates HIV-1 Sensitivity to VRC01-Mediated Prevention

Background: HIV-1 envelope glycoproteins (Envs) mediate viral entry and are the sole target of neutralizing antibodies. Envs of most primary HIV-1 strains exist in a closed conformation and occasionally sample more open Env states. Thus, current knowledge guides immunogen design to mimic the closed Env conformation as the preferred target for eliciting broadly neutralizing antibodies…

HIResist: A Database of HIV-1 Resistance to Broadly Neutralizing Antibodies

Background: Changing the course of the human immunodeficiency virus type I (HIV-1) pandemic is a high public health priority with approximately 39 million people currently living with HIV-1 (PLWH) and about 1.5 million new infections annually worldwide. Broadly neutralizing antibodies (bnAbs) target vulnerable sites on HIV-1 envelope glycoproteins (Envs), which mediate viral entry, and block…

High-Level Resistance to Integrase Inhibitors Conferred by Mutations Outside Integrase

Background: Second-generation integrase (IN) strand transfer inhibitors (INSTIs) are highly potent antiretroviral compounds that exhibit a high genetic barrier to resistance. Recent clinical studies concluded that some INSTI-treated individuals experience virological failure in the absence of resistance mutations in IN. The aim of the study is to elucidate INSTI resistance mechanisms and pathways. Methods: One-year…